1. Home
  2. THH vs QNCX Comparison

THH vs QNCX Comparison

Compare THH & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

THH

TryHard Holdings Limited Ordinary Shares

HOLD

Current Price

$0.38

Market Cap

17.1M

Sector

N/A

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$1.09

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THH
QNCX
Founded
2013
2012
Country
Japan
United States
Employees
116
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1M
19.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
THH
QNCX
Price
$0.38
$1.09
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
87.0K
1.5M
Earning Date
05-19-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$305.05
$0.37
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.08
52 Week High
$56.26
$4.55

Technical Indicators

Market Signals
Indicator
THH
QNCX
Relative Strength Index (RSI) 51.76 49.56
Support Level $0.31 $0.10
Resistance Level $0.54 $1.50
Average True Range (ATR) 0.03 0.11
MACD 0.02 -0.05
Stochastic Oscillator 80.14 50.89

Price Performance

Historical Comparison
THH
QNCX

About THH TryHard Holdings Limited Ordinary Shares

Tryhard Holdings Ltd is a Japan-based lifestyle entertainment company offering services across the entertainment and hospitality sectors. Its main businesses include event curation, consultancy and management, sub-leasing of venues, and restaurant operations. The company operates through four segments, with the majority of revenue generated from consultancy and management, which provides club planning, operations, event production, entertainer bookings, and sponsorship services. The event curation segment produces both in-house and client events; the sub-leasing segment rents venues and sub-leases them to clubs; and the restaurants segment operates themed dining outlets that complement its entertainment offerings.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: